Literature DB >> 17188765

Targeted identification of a unique glycan epitope of Schistosoma mansoni egg antigens using a diagnostic antibody.

Marjolein L M Robijn1, Carolien A M Koeleman, Manfred Wuhrer, Louise Royle, Rudolf Geyer, Raymond A Dwek, Pauline M Rudd, André M Deelder, Cornelis H Hokke.   

Abstract

The eggs of Schistosoma mansoni express a plethora of glycoconjugate antigens. A specific subset of these antigens can be detected in the serum or urine of infected individuals by a diagnostic sandwich ELISA using the anti-carbohydrate monoclonal antibody (mAb) 114-4D12-A [Nourel Din MS, Nibbeling R, Rotmans JP, Polderman AM, Krijger FW, Deelder AM. Quantitative determination of circulating soluble egg antigen in urine and serum of Schistosoma mansoni-infected individuals using a combined two-site enzyme-linked immunosorbent assay. Am J Trop Med Hyg 1994;50:585-94]. We used affinity chromatography to isolate the 114-4D12-binding glycoprotein subset from soluble egg antigens (SEA) of S. mansoni. SEA and the isolated SEA-subset (SEA-4D12) were subjected to reductive beta-elimination and hydrazinolysis to release intact glycans and glycan fragments, respectively, from the protein backbones. The released glycans were characterised by matrix-assisted laser-desorption-ionisation time-of-flight (MALDI-TOF) mass spectrometry (MS), liquid-chromatography (LC)-MS and gas chromatography (GC)-MS linkage analysis. Glycans released by reductive beta-elimination from SEA-4D12 were larger and more heavily fucosylated than glycans released from SEA. Most SEA-4D12 glycans contained a branched O-glycan core structure carrying up to 4 N-acetylhexosamines per chain which were substituted with maximum 12 fucose residues. Hydrazinolysis of SEA-4D12 resulted in the release of fucosylated antenna fragments. After 2-aminobenzamide (2AB)-labelling these fragments were subjected to 114-4D12-affinity purification. Normal phase (NP)-LC analysis of the flow-through and retained fractions indicated that the Fucalpha1-2Fucalpha1-3GalNAcbeta1-4(Fucalpha1-2Fucalpha1-3)GlcNAcbeta1- element forms the epitope of mAb 114-4D12. Most O-glycans from SEA-4D12 contain this structural element. Epitope-bearing N-glycans have not been found. In terms of abundance in total SEA, only a minority of all glycans possesses the epitope. This multifucosylated motif has so far only been found in schistosomes, providing a structural basis for the high specificity of the diagnostic antibody.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17188765     DOI: 10.1016/j.molbiopara.2006.10.019

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  12 in total

1.  Evaluation of an IgY-based immunomagnetic enzyme-linked immunosorbent assay system for detection of circulating Schistosoma japonicum antigen in serum samples from patients in China.

Authors:  Jia-hui Lei; Bing-tao Su; Hong Xu; Ji-long Shen; Xiao-hong Guan; Zhen-qing Feng; Yong-long Li; Ming-xing Xu; Wen-qi Liu
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  Immunization with recombinantly expressed glycan antigens from Schistosoma mansoni induces glycan-specific antibodies against the parasite.

Authors:  Nina Salinger Prasanphanich; Anthony E Luyai; Xuezheng Song; Jamie Heimburg-Molinaro; Msano Mandalasi; Megan Mickum; David F Smith; A Kwame Nyame; Richard D Cummings
Journal:  Glycobiology       Date:  2014-04-11       Impact factor: 4.313

3.  Mass spectrometric identification of aberrantly glycosylated human apolipoprotein C-III peptides in urine from Schistosoma mansoni-infected individuals.

Authors:  Crina I A Balog; Oleg A Mayboroda; Manfred Wuhrer; Cornelis H Hokke; André M Deelder; Paul J Hensbergen
Journal:  Mol Cell Proteomics       Date:  2010-01-13       Impact factor: 5.911

4.  Identification of Antigenic Glycans from Schistosoma mansoni by Using a Shotgun Egg Glycan Microarray.

Authors:  Megan L Mickum; Nina Salinger Prasanphanich; Xuezheng Song; Nelum Dorabawila; Msano Mandalasi; Yi Lasanajak; Anthony Luyai; W Evan Secor; Patricia P Wilkins; Irma Van Die; David F Smith; A Kwame Nyame; Richard D Cummings; Carlos A Rivera-Marrero
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

5.  Glycotope analysis in miracidia and primary sporocysts of Schistosoma mansoni: differential expression during the miracidium-to-sporocyst transformation.

Authors:  Nathan A Peterson; Cornelis H Hokke; André M Deelder; Timothy P Yoshino
Journal:  Int J Parasitol       Date:  2009-06-21       Impact factor: 3.981

6.  Glycomic Analysis of Life Stages of the Human Parasite Schistosoma mansoni Reveals Developmental Expression Profiles of Functional and Antigenic Glycan Motifs.

Authors:  Cornelis H Smit; Angela van Diepen; D Linh Nguyen; Manfred Wuhrer; Karl F Hoffmann; André M Deelder; Cornelis H Hokke
Journal:  Mol Cell Proteomics       Date:  2015-04-16       Impact factor: 5.911

Review 7.  Glycoconjugates in host-helminth interactions.

Authors:  Nina Salinger Prasanphanich; Megan L Mickum; Jamie Heimburg-Molinaro; Richard D Cummings
Journal:  Front Immunol       Date:  2013-08-28       Impact factor: 7.561

8.  Excreted/secreted Schistosoma mansoni venom allergen-like 9 (SmVAL9) modulates host extracellular matrix remodelling gene expression.

Authors:  Timothy P Yoshino; Martha Brown; Xiao-Jun Wu; Colin J Jackson; Ramon Ocadiz-Ruiz; Iain W Chalmers; Marlen Kolb; Cornelis H Hokke; Karl F Hoffmann
Journal:  Int J Parasitol       Date:  2014-05-21       Impact factor: 3.981

Review 9.  Development of "-omics" research in Schistosoma spp. and -omics-based new diagnostic tools for schistosomiasis.

Authors:  Shuqi Wang; Wei Hu
Journal:  Front Microbiol       Date:  2014-06-26       Impact factor: 5.640

Review 10.  Deciphering the glycogenome of schistosomes.

Authors:  Megan L Mickum; Nina S Prasanphanich; Jamie Heimburg-Molinaro; Kristoffer E Leon; Richard D Cummings
Journal:  Front Genet       Date:  2014-08-05       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.